Return to homepagePandemic Pact

Nasal spray development for bovine colostrum-derived antibodies against SARS-CoV-2 (COVID-19) and influenza viruses

Grant number: LMVFA23163

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2023

  • Known Financial Commitments (USD)

    $39,840

  • Funder

    Estonian Research Council

  • Principal Investigator

    Kogermann Karin

  • Research Location

    Estonia

  • Lead Research Institution

    University of Tartu

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine design and administration

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    N/A

Abstract

It has been shown that intranasal administration of antibodies might provide a powerful, affordable and flexible tool to provide protection in the upper respiratory tract, the portal of entry of virus infections. The project aims to develop nasal spray formulations consisting antibodies against viruses and their quality analyses.